Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Willow Biosciences has demonstrated significant revenue growth in 2024 with record quarterly revenues of $1 million and projected annual revenues over $4 million. The company has successfully transitioned several programs from R&D to commercial production through strategic partnerships such as with Laurus Labs. It specializes in precision fermentation-based production of high-value APIs and functional ingredients for pharma, food & beverage, and personal care markets[9]. No direct clinical trial results are reported since the business model centers on ingredient supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Willow Biosciences.